Literature DB >> 30105437

Correction to: Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.

Jeffrey E Gershenwald1,2, Richard A Scolyer3,4,5.   

Abstract

In the original article, there were errors in Fig. 1a. Following is the corrected figure.

Entities:  

Year:  2018        PMID： 30105437     DOI： 10.1245/s10434-018-6689-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


  3 in total

Review 1.  [Sentinel node biopsy and lymph node dissection in the era of new systemic therapies for malignant melanoma].

Authors:  A Ulmer; L Kofler
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

2.  Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study.

Authors:  Paolo Del Fiore; Marco Rastrelli; Luigi Dall'Olmo; Francesco Cavallin; Rocco Cappellesso; Antonella Vecchiato; Alessandra Buja; Romina Spina; Alessandro Parisi; Renzo Mazzarotto; Beatrice Ferrazzi; Andrea Grego; Alessio Rotondi; Clara Benna; Saveria Tropea; Francesco Russano; Angela Filoni; Franco Bassetto; Angelo Paolo Dei Tos; Mauro Alaibac; Carlo Riccardo Rossi; Jacopo Pigozzo; Vanna Chiarion Sileni; Simone Mocellin
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 6.244

3.  Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143).

Authors:  Marco Rastrelli; Paolo Del Fiore; Irene Russo; Jacopo Tartaglia; Alessandro Dal Monico; Rocco Cappellesso; Lorenzo Nicolè; Luisa Piccin; Alessio Fabozzi; Bernardo Biffoli; Claudia Di Prata; Beatrice Ferrazzi; Luigi Dall'Olmo; Antonella Vecchiato; Romina Spina; Francesco Russano; Elisabetta Bezzon; Sara Cingarlini; Renzo Mazzarotto; Alessandro Parisi; Giovanni Scarzello; Jacopo Pigozzo; Tito Brambullo; Saveria Tropea; Vincenzo Vindigni; Franco Bassetto; Daniele Bertin; Michele Gregianin; Angelo Paolo Dei Tos; Francesco Cavallin; Mauro Alaibac; Vanna Chiarion-Sileni; Simone Mocellin
Journal:  Front Oncol       Date:  2021-12-17       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.